市場調查報告書
商品編碼
1465966
顯影劑市場:按類型、程序、給藥途徑、應用、最終用戶、適應症分類 - 2024-2030 年全球預測Contrast Media Market by Type, Procedure, Route Of Administration, Application, End-user, Disease Indication - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年顯影劑市場規模為36.7億美元,預計2024年將達40.2億美元,2030年將達到70.4億美元,複合年成長率為9.75%。
顯影劑是用於醫學影像處理的物質,可提高體內組織、器官和其他結構的可見度。它的工作原理是改變電腦斷層掃描 (CT)、X 光、超音波掃描和磁振造影(MRI) 等影像處理設備與您的身體相互作用的方式。透過增加所得影像的對比度,這些試劑可以提供更清晰的測試區域影像,有助於準確診斷和評估各種疾病。診斷影像技術的不斷創新正在推動新型顯影劑的開發。然而,由於顯影劑的潛在副作用,越來越多的患者安全擔憂阻礙了顯影劑採用。先進顯影劑製造程序的整合和奈米顆粒的新興滲透在影像處理程序中提供了卓越的性能,為顯影劑市場的擴張提供了有利可圖的機會。
主要市場統計 | |
---|---|
基準年[2023] | 36.7億美元 |
預測年份 [2024] | 40.2億美元 |
預測年份 [2030] | 70.4億美元 |
複合年成長率(%) | 9.75% |
類型:對準確診斷方式的需求增加了碘顯影劑的使用
鋇顯影劑主要用於胃腸道 (GI) 影像,包括胃、腸和食道。根據測試部位,這些化合物可以口服或直腸給藥。钆基顯影劑覆蓋胃腸道內壁,透過突顯潰瘍、息肉和腫瘤等異常情況,有效提供胃腸道的詳細影像。钆基顯影劑主要用於磁振造影(MRI),以增強影像清晰度和細節。這些顯影劑提高了身體各部位的血管、發炎、腫瘤和腫瘤血管的可見度。钆在神經、肌肉骨骼和心血管成像中特別有用。含碘藥物廣泛用於電腦斷層掃描 (CT)、血管造影術和造影。這些藥物通常透過靜脈注射,並以其透過與周圍組織不同的方式吸收或散射 X光來增強不同身體結構或血管內液體之間的對比度的能力而聞名。碘顯影劑可用於觀察血管、辨識腫瘤、規劃內科和外科治療。微氣泡顯影劑是專門設計的超音波影像的試劑,用於增強體內血液和體液的對比。充滿氣體的微氣泡透過靜脈注射,對於心臟和血管的診斷成像特別有用。微氣泡顯影劑可以使血流、心臟功能可視化,並檢測肝臟和其他器官的異常。
應用:介入性放射線顯影劑採用率高
介入性心臟病學中的顯影劑對於增強基於導管的手術期間心血管解剖和病理學的可視化至關重要。這些介質可以清楚地顯示冠狀動脈,從而更容易診斷冠狀動脈疾病和評估病變的嚴重程度。它對於提供即時影像也至關重要,這些影像可以作為支架置入和球囊血管成形術的指南,並且可以作為介入性心臟病專家的判斷依據。在介入放射學中,顯影劑在影像引導下進行的微創手術中增強了器官、血管和組織的可見度。這些應用包括腫瘤栓塞術(使用顯影劑來闡明腫瘤的血管解剖結構並輔助標靶治療)、顯影劑來可視化需要擴大的狹窄血管)以及各種靜脈結構。 。在放射學中,顯影劑對於增強放射線照片、 電腦斷層掃描和 MRI 影像、提高不同身體部位之間的對比度以及幫助診斷疾病和病症非常重要。在電腦斷層掃描中,碘造影顯影劑勾勒出血管輪廓並突出顯示感興趣的區域,如腹部、骨盆和大腦,有效診斷感染疾病、發炎疾病、癌症和血管疾病。在 MRI 檢查中,钆基顯影劑用於增加異常組織和正常組織之間的對比度,這對於神經性大腦狀況、肌肉骨骼異常和腫瘤評估等詳細評估非常有用。
區域洞察
美洲,特別是美國和加拿大,先進醫學影像技術的採用率很高。美國是醫療創新中心,旨在減少副作用和提高影像清晰度的新配方專利數量迅速增加。加拿大顯影劑市場受益於成熟的醫療保健系統和政府促進診斷影像研究的舉措。美國消費者的購買行為受到對品質和安全的重視以及對早期診斷益處的高度認知的影響。亞太地區,特別是中國、日本和印度,已成為顯影劑的重要成長市場。不斷增加的醫療基礎設施、對疾病早期診斷的認知以及人口老化的加劇正在推動亞太地區對顯影劑的需求。在中國,最近旨在提高顯影劑安全性和有效性的專利凸顯了該國的研發努力。日本以其強大的醫療保健系統而聞名,並優先考慮創新的成像技術,這鼓勵了先進的造影顯影劑使用。印度顯影劑市場的特點是增加對醫療保健的投資,並專注官民合作關係(PPP)以加強診斷服務。在歐洲、中東和非洲(Europe、Middle East、Africa),歐洲國家重點加強利用高階技術的診斷影像服務,情況多元。與媒體生產和使用相比,該地區正在積極採用更環保的做法,反映出人們對環境永續性和病人安全的認知不斷增強。在醫療基礎設施快速發展的中東,由於對醫療設施的投資以及對研究和創新的重視,對顯影劑的需求不斷增加。由於市場開拓、醫療成本不斷上升以及人們對非侵入性診斷方法的認知不斷增強,非洲顯影劑市場具有擴張潛力。
FPNV定位矩陣
FPNV定位矩陣對於評估顯影劑市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限。最前線 (F)、探路者 (P)、利基 (N) 和重要 (V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對顯影劑市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該細分市場競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:包括新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:包括對未來技術、研發活動以及突破性產品開發的見解。
1.顯影劑市場規模及預測如何?
2.在顯影劑市場的預測期內,我們應該考慮投資哪些產品和應用?
3.顯影劑市場的技術趨勢和法規結構是什麼?
4.顯影劑市場主要廠商的市場佔有率是多少?
5. 進入顯影劑市場的合適型態和策略手段是什麼?
[190 Pages Report] The Contrast Media Market size was estimated at USD 3.67 billion in 2023 and expected to reach USD 4.02 billion in 2024, at a CAGR 9.75% to reach USD 7.04 billion by 2030.
Contrast media are substances used in medical imaging to enhance the visibility of tissues, organs, and other structures inside the body. They work by altering how imaging tools, such as computed tomography (CT), X-rays, ultrasound scans, and magnetic resonance imaging (MRI), interact with the body. By improving the contrast of the images obtained, these agents help provide a clearer picture of the area being examined, aiding in the accurate diagnosis and assessment of various conditions. The increasing innovations in imaging technologies are boosting the development of new contrast agents. However, the rising patient safety concerns due to potential adverse reactions to contrast agents hinder the adoption of contrast media. Integration of advanced contrast media manufacturing procedures and the emerging penetration of nanoparticles offering superior performance in imaging procedures offer remunerative opportunities for the expansion of the contrast media market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.67 billion |
Estimated Year [2024] | USD 4.02 billion |
Forecast Year [2030] | USD 7.04 billion |
CAGR (%) | 9.75% |
Type: Rising use of iodinated contrast media owing to the demand for accurate diagnostic modalities
Barium-based contrast media are primarily used in gastrointestinal (GI) imaging, including stomach, intestines, and esophagus exams. These compounds are ingested orally or administered rectally, depending on the area of interest. They effectively provide detailed images of the GI tract by coating the lining and highlighting abnormalities such as ulcers, polyps, or tumors. Gadolinium-based contrast agents are primarily utilized in Magnetic Resonance Imaging (MRI) to enhance the clarity and detail of the images. These agents improve the visibility of blood vessels, inflammation, tumors, and the vascularity of tumors in various body parts. Gadolinium is particularly beneficial in neurological, musculoskeletal, and cardiovascular imaging. Iodinated contrast media are widely used in computed tomography (CT) scans, angiography, and venography. These agents are typically injected intravenously and are known for their ability to enhance the contrast between different body structures or fluids within vessels by absorbing or scattering X-rays differently than surrounding tissues. Iodinated contrast media are invaluable in visualizing blood vessels, identifying tumors, and planning medical or surgical treatment. Microbubble contrast media are specially designed agents used in ultrasound imaging to enhance the contrast of blood or fluids within the body. These gas-filled microbubbles are injected intravenously and are particularly useful in cardiac and vascular imaging. Microbubble contrast media enable the visualization of blood flow, the function of the heart, and the detection of abnormalities in the liver and other organs.
Application: High adoption of contrast media in interventional radiology
Contrast media in interventional cardiology are pivotal for enhancing the visualization of cardiovascular anatomy and pathology during catheter-based procedures. These media allow for the clear delineation of coronary arteries, facilitating the diagnosis of coronary artery disease and assessing lesion severity. They are indispensable in guiding stent placement or balloon angioplasty by providing real-time images that inform the interventional cardiologist's decisions. In interventional radiology, contrast media enhances the visibility of organs, blood vessels, and tissues during minimally invasive procedures conducted under image guidance. These applications include tumor embolization, where the contrast helps define the vascular anatomy of tumors for targeted treatment; vascular angioplasty, with contrast media delineating narrowed vessels needing dilation; and venous sampling, which enables the differentiation of various venous structures. In radiology, contrast media are crucial in enhancing radiographs, CT scans, and MRI images, improving the contrast between different body parts to help diagnose diseases and conditions. In CT scans, iodinated contrast media outline blood vessels and highlight areas of interest in the abdominal and pelvic region, brain, and more, effectively diagnosing infections, inflammatory conditions, cancers, and vascular diseases. In MRI scans, gadolinium-based contrast agents are employed to increase the contrast between abnormal and normal tissue, making them invaluable in the detailed evaluation of neurological brain conditions, musculoskeletal anomalies, and assessment of tumors.
Regional Insights
In the Americas, particularly in the United States and Canada, there is a high adoption rate of advanced medical imaging technologies. The United States, being a hub for medical innovation, has seen a surge in patents related to novel contrast media formulations aiming for reduced side effects and improved imaging clarity. The contrast media market in Canada benefits from a well-established healthcare system and government initiatives promoting research in diagnostic imaging. Customer purchasing behavior in American countries is influenced by a strong emphasis on quality and safety and a high level of awareness about the benefits of early diagnosis. The Asia Pacific region, particularly China, Japan, and India, is emerging as a significantly growing market for contrast media. The increasing healthcare infrastructure, awareness regarding early disease diagnosis, and a growing aging population drive the demand for contrast media in the Asia-Pacific region. In China, recent patents aimed at enhancing the safety and efficacy of contrast agents highlight the country's commitment to research and development. Japan, known for its robust healthcare system, prioritizes innovative imaging technologies, thereby boosting the use of advanced contrast media. In India, the contrast media market is characterized by increasing investment in healthcare and a growing focus on public-private partnerships (PPPs) to enhance diagnostic services. In the EMEA region, Europe exhibits a diverse landscape, with EU countries focusing on enhancing imaging services through high-end technologies. The region actively embraces greener practices in contrast to media production and usage, reflecting a growing consciousness towards environmental sustainability alongside patient safety. The Middle East, amid its burgeoning healthcare infrastructure, shows a growing demand for contrast media driven by investments in healthcare facilities and a growing emphasis on research and innovation. The contrast media market in Africa presents potential for expansion owing to its untapped markets, increasing healthcare expenditure, and rising awareness about non-invasive diagnostic methods.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Contrast Media Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Contrast Media Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Contrast Media Market, highlighting leading vendors and their innovative profiles. These include Acro Lifesciences (I) Pvt. Ltd., Bayer AG, Beijing Beilu Pharmaceutical Co., Ltd., Bracco Spa, Covis Group, Daiichi Sankyo Co. Ltd., Fuji Pharma Co. Ltd., GE Healthcare Co., Ltd., Guerbet SA, iMAX Diagnostic Imaging Limited, J. B. Chemicals & Pharmaceuticals Limited, Jodas Expoim Pvt. Ltd., Lantheus Medical Imaging, Inc., M.Biotech Limited, Miltenyi Biotec B.V. & Co. KG, Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd., nanoPET Pharma GmbH, SANOCHEMIA Pharmazeutika GmbH, Spago Nanomedical AB, Trivitron Healthcare, and Vitalquan, LLC.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Contrast Media Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Contrast Media Market?
3. What are the technology trends and regulatory frameworks in the Contrast Media Market?
4. What is the market share of the leading vendors in the Contrast Media Market?
5. Which modes and strategic moves are suitable for entering the Contrast Media Market?